Mathieu Lefebvre

Mathieu Lefebvre is a seasoned professional in the pharmaceutical and medical fields, currently serving as a Medical Science Liaison and Medical Advisor at Bristol-Myers Squibb since February 2020, where support focuses on pre-launch activities for deucravacitinib in dermatology and ongoing medical activities in rheumatology. Previous experience includes a role as a Global Medical Strategy Resident at Sanofi Pasteur, where Mathieu developed medical content and led strategic document updates for the influenza franchise. Mathieu's extensive background encompasses various pharmacy residencies, including clinical trials vigilance and sterile medical device management, as well as experience in academic settings as a lecturer and in pharmaceutical preparation. Educational qualifications include a Specialized Education Degree in Industrial and Biomedical Pharmacy, a Master of Science in Vaccinology, a Doctor of Pharmacy, and additional credentials in Medical Statistics.